Pharmacogenomics of anti-TB drugs-related hepatotoxicity

Author： Roy Puspita Das   Majumder Mousumi   Roy Bidyut  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.3, 2008-03, pp. : 311-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adverse Drug Reactions to Anti-TB Drugs: Pharmacogenomics Perspective for Identification of Host Genetic Markers

By  

Current Drug Metabolism, Vol. 16, Iss. 7, 2015-09 ,pp. : 538-552

Bentham Science Publishers

Access to resources Recommend Favorite

High prevalence of resistance to second-line anti-TB drugs

By  

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

By Possuelo L.   Castelan J.   Brito T.   Ribeiro A.   Cafrune P.   Picon P.   Santos A.   Teixeira R.   Gregianini T.   Hutz M.   Rossetti M.   Zaha A.  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 7, 2008-07 ,pp. : 673-681

Springer Publishing Company

Access to resources Recommend Favorite

Immunisation fund tops $US1b, WHO calls for free anti-TB drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1177-1185

Bentham Science Publishers

Access to resources Recommend Favorite